Announcement of Intent To Issue Replacement Award To Provide Residential Services (Shelter), 67956 [2021-25970]
Download as PDF
<![CDATA[
67956
Federal Register / Vol. 86, No. 227 / Tuesday, November 30, 2021 / Notices
Linda Hitt,
ACF Certifying Officer.
[FR Doc. 2021–26102 Filed 11–26–21; 4:15 pm]
BILLING CODE 4184–74–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Number: 93.676]
Announcement of Intent To Issue
Replacement Award To Provide
Residential Services (Shelter)
Office of Refugee Resettlement
(ORR), Administration for Children and
Families (ACF), Department of Health
and Human Services (HHS).
ACTION: Notice of issuance of
Replacement Award to Lutheran Social
Services of the South Upbring (LSS
Upbring).
AGENCY:
ACF, ORR announces the
intent to award a Replacement Award to
LSS Upbring in the amount of up to
$20,929,074 in Brownsville, Texas. On
September 17, 2021, Comprehensive
Health Services, LLC (CHS)
relinquished a federally funded
discretionary grant. Per HHS policy,
ORR has identified current recipient
LSS Upbring to transfer the current
permanent capacity to provide shelter
for apprehensions of Unaccompanied
Children (UC) at the Southwest Border.
The continuation of permanent capacity
is a prudent step to ensure that ORR is
able to meet its responsibility, by law,
to provide shelter and appropriate
services for UC referred to its care by the
Department of Homeland Security. The
purpose of this award is to ensure the
continuation of residential services for
the capacity of 76 shelter beds for UC.
DATES: The proposed period of
performance is December 1, 2021–
September 30, 2022.
FOR FURTHER INFORMATION CONTACT:
Stephen Antkowiak, Office of Refugee
Resettlement, Division of
Unaccompanied Children Operations,
330 Street SW, Washington, DC 20447.
Phone: 202–260–6165. Email:
stephen.antkowiak@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: ORR
announces the intent to award a
Replacement Award to LSS Upbring in
the amount of up to $20,929,074. This
award will prevent the disruption in
residential services currently available
at the CHS Loma Alta location and
prevent children unnecessarily pending
placement from Border Patrol.
ORR has specific requirements for the
provision of services. Award recipients
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:17 Nov 29, 2021
Jkt 256001
must have the infrastructure, licensing if
applicable, experience, and appropriate
level of trained staff to meet those
requirements.
Statutory Authority: This program is
authorized by—
(A) Section 462 of the Homeland
Security Act of 2002, which in March
2003, transferred responsibility for the
care and custody of UC from the
Commissioner of the former
Immigration and Naturalization Service
to the Director of ORR within HHS.
(B) The Flores Settlement Agreement,
Case No. CV85–4544–RJK (C.D. Cal.
1996), as well as the William
Wilberforce Trafficking Victims
Protection Reauthorization Act of 2008
(Pub. L. 110–457), which authorizes
post release services under certain
conditions to eligible children. All
programs must comply with the Flores
Settlement Agreement, Case No. CV85–
4544–RJK (C.D. Cal. 1996); pertinent
regulations; and ORR policies and
procedures.
Elizabeth Leo,
Senior Grants Policy Specialist, Office of
Grants Policy, Office of Administration.
[FR Doc. 2021–25970 Filed 11–29–21; 8:45 am]
BILLING CODE 4184–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2021–D–1146]
Real-World Data: Assessing Registries
To Support Regulatory DecisionMaking for Drug and Biological
Products; Draft Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
guidance for industry entitled ‘‘RealWorld Data: Assessing Registries to
Support Regulatory Decision-Making for
Drug and Biological Products.’’ FDA is
issuing this guidance as part of its RealWorld Evidence (RWE) Program and to
satisfy, in part, the mandate under the
Federal Food, Drug, and Cosmetic Act
(FD&C Act) to issue guidance about the
use of RWE in regulatory decisionmaking. This guidance provides
sponsors and other stakeholders with
considerations when either proposing to
design a registry or using an existing
registry to support regulatory decisionmaking about a drug’s effectiveness or
safety.
SUMMARY:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Submit either electronic or
written comments on the draft guidance
by February 28, 2022 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2021–D–1146 for ‘‘Real-World Data:
Assessing Registries to Support
Regulatory Decision-Making for Drug
and Biological Products.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
E:\FR\FM\30NON1.SGM
30NON1
]]>Agencies
[Federal Register Volume 86, Number 227 (Tuesday, November 30, 2021)]
[Notices]
[Page 67956]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25970]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
[CFDA Number: 93.676]
Announcement of Intent To Issue Replacement Award To Provide
Residential Services (Shelter)
AGENCY: Office of Refugee Resettlement (ORR), Administration for
Children and Families (ACF), Department of Health and Human Services
(HHS).
ACTION: Notice of issuance of Replacement Award to Lutheran Social
Services of the South Upbring (LSS Upbring).
-----------------------------------------------------------------------
SUMMARY: ACF, ORR announces the intent to award a Replacement Award to
LSS Upbring in the amount of up to $20,929,074 in Brownsville, Texas.
On September 17, 2021, Comprehensive Health Services, LLC (CHS)
relinquished a federally funded discretionary grant. Per HHS policy,
ORR has identified current recipient LSS Upbring to transfer the
current permanent capacity to provide shelter for apprehensions of
Unaccompanied Children (UC) at the Southwest Border. The continuation
of permanent capacity is a prudent step to ensure that ORR is able to
meet its responsibility, by law, to provide shelter and appropriate
services for UC referred to its care by the Department of Homeland
Security. The purpose of this award is to ensure the continuation of
residential services for the capacity of 76 shelter beds for UC.
DATES: The proposed period of performance is December 1, 2021-September
30, 2022.
FOR FURTHER INFORMATION CONTACT: Stephen Antkowiak, Office of Refugee
Resettlement, Division of Unaccompanied Children Operations, 330 Street
SW, Washington, DC 20447. Phone: 202-260-6165. Email:
[email protected].
SUPPLEMENTARY INFORMATION: ORR announces the intent to award a
Replacement Award to LSS Upbring in the amount of up to $20,929,074.
This award will prevent the disruption in residential services
currently available at the CHS Loma Alta location and prevent children
unnecessarily pending placement from Border Patrol.
ORR has specific requirements for the provision of services. Award
recipients must have the infrastructure, licensing if applicable,
experience, and appropriate level of trained staff to meet those
requirements.
Statutory Authority: This program is authorized by--
(A) Section 462 of the Homeland Security Act of 2002, which in
March 2003, transferred responsibility for the care and custody of UC
from the Commissioner of the former Immigration and Naturalization
Service to the Director of ORR within HHS.
(B) The Flores Settlement Agreement, Case No. CV85-4544-RJK (C.D.
Cal. 1996), as well as the William Wilberforce Trafficking Victims
Protection Reauthorization Act of 2008 (Pub. L. 110-457), which
authorizes post release services under certain conditions to eligible
children. All programs must comply with the Flores Settlement
Agreement, Case No. CV85-4544-RJK (C.D. Cal. 1996); pertinent
regulations; and ORR policies and procedures.
Elizabeth Leo,
Senior Grants Policy Specialist, Office of Grants Policy, Office of
Administration.
[FR Doc. 2021-25970 Filed 11-29-21; 8:45 am]
BILLING CODE 4184-45-P
